Related Experiment Videos
Chronic kidney disease in solid-organ transplantation.
1Renal Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63108, USA. bmiller@wustl.edu
Advances in Chronic Kidney Disease
|January 18, 2006
Summary
Chronic kidney disease (CKD) affects many long-term survivors of organ transplants. This review covers CKD incidence, risk factors, treatment, and outcomes in heart, liver, and lung transplant recipients.
Area of Science:
- Nephrology
- Transplant Medicine
- Immunology
Background:
- Long-term survival rates for nonrenal solid-organ transplant recipients are increasing.
- Chronic kidney disease (CKD) is a significant complication in this growing population.
- Previously underestimated, CKD affects a substantial number of transplant recipients, especially long-term survivors.
Purpose of the Study:
- To review the incidence, risk factors, treatment, and outcomes of CKD in nonrenal solid-organ transplant recipients.
- To highlight the increasing prevalence of CKD in patients with successful primary allograft function.
- To provide a comprehensive overview for clinicians managing post-transplant complications.
Main Methods:
- Literature review of studies on CKD in heart, liver, and lung transplant recipients.
- Analysis of data on kidney function monitoring and CKD complication assessment.
- Synthesis of information regarding risk factors, therapeutic strategies, and patient outcomes.
Main Results:
- CKD is more prevalent than previously recognized in long-term transplant survivors.
- Key risk factors for developing CKD post-transplantation are identified.
- Effective management strategies and their impact on outcomes are discussed.
Conclusions:
- CKD is a common and serious complication in nonrenal solid-organ transplant recipients.
- Early detection and management of CKD are crucial for improving long-term outcomes.
- Further research is needed to optimize prevention and treatment protocols for post-transplant CKD.